BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
66 hedge funds and large institutions have $213M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
66
Holding in Top 10
–
Calls
$103K
Puts
–
Top Buyers
| 1 | +$10.3M | |
| 2 | +$5.86M | |
| 3 | +$2.75M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$2.56M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$1.78M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$4.7M | |
| 3 | -$3.96M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$2.23M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.53M |